Cervical cancer screening firm TruScreen to list on small-cap NZAX

Cervical cancer screening firm TruScreen to list on small-cap NZAX
By Paul McBeth Nov. 5 (BusinessDesk) - TruScreen, which develops a cervical cancer screening system, plans to join the small-cap NZX Alternative Market next week in a compliance listing. The Auckland-based company will list its 144.4 million ordinary shares on the NZAX on Nov. 12 and won't issue new shares, according to a notice to the stock exchange. TruScreen raised $6.07 million in the 2014 financial year selling shares at 10 cents apiece, according to its annual report, and a fact sheet on its website put the current share price at 10...